Califf Nomination Hearing Expected Before Holiday Season
This article was originally published in The Tan Sheet
The Senate HELP Committee has competing priorities, but the FDA commissioner nominee still seems to have smooth path to confirmation.
You may also be interested in...
After seven months as deputy commissioner for medical products and tobacco, Robert Califf tapped to be FDA Commissioner.
In an interview with “The Pink Sheet,” new deputy commissioner for medical products says FDA needs better ways of helping stakeholders, public understand agency thinking.
Sanders casts the lone dissenting vote, saying it does not do enough to curb drug costs. Pay-for-delay and drug reimportation amendments fail.